Vicore Pharma Holding AB (publ) (FRA:6Y4)
Germany
· Delayed Price · Currency is EUR 0.9080
+0.0200 (2.25%)
At close: Dec 4, 2025
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 760.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 8.50M, down -91.85% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
8.50M SEK
Revenue Growth
-91.85%
P/S Ratio
343.50
Revenue / Employee
293.14K SEK
Employees
29
Market Cap
264.12M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |